CFTR and metabolic syndrome: In comparison to ETI-exposed newborns, all these groups exhibited higher mean levels of immunoreactive trypsinogen: 191.6 ng/mL in newborns with CF, 96.7 ng/mL in those with CFTR-related metabolic syndrome, and 66.9 ng/mL in CF carriers.